Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial

被引：0
|
作者：
Stefan Knop
Maria-Victoria Mateos
Meletios A. Dimopoulos
Kenshi Suzuki
Andrzej Jakubowiak
Chantal Doyen
Paulo Lucio
Zsolt Nagy
Ganna Usenko
Ludek Pour
Mark Cook
Sebastian Grosicki
Andre Crepaldi
Anna Marina Liberati
Philip Campbell
Tatiana Shelekhova
Sung-Soo Yoon
Genadi Losava
Tomoaki Fujisaki
Mamta Garg
Jianping Wang
Susan Wroblewski
Anupa Kudva
Katharine S. Gries
John Fastenau
Jesus San-Miguel
Michele Cavo
机构：
[1] Würzburg University Medical Center,Department of Haematology and Oncology
[2] University Hospital of Salamanca–Instituto de Investigación Biomédica de Salamanca,Department of Internal Medicine
[3] National and Kapodistrian University of Athens,Institute of Hematology, Department of Experimental, Diagnostic and Specialty Medicine
[4] Japanese Red Cross Medical Center,undefined
[5] University of Chicago Medical Center,undefined
[6] Université Catholique of Louvain,undefined
[7] CHU UCL Namur,undefined
[8] Champalimaud Centre for the Unknown,undefined
[9] Semmelweis University,undefined
[10] Dnipropetrovsk City Multidisciplinary Clinical Hospital No. 4,undefined
[11] University Hospital Brno,undefined
[12] University Hospitals Birmingham NHS Trust,undefined
[13] Silesian Medical University,undefined
[14] Clinica de Tratamento E,undefined
[15] Azienda Ospedaliera “Santa Maria”,undefined
[16] Andrew Love Cancer Centre,undefined
[17] Clinic of Professional Pathology,undefined
[18] Seoul National University College of Medicine,undefined
[19] LTD “Medinvent” Institute of Health,undefined
[20] Matsuyama Red Cross Hospital,undefined
[21] Leicester Royal Infirmary,undefined
[22] Janssen Research and Development,undefined
[23] Janssen Research & Development,undefined
[24] LLC,undefined
[25] Clínica Universidad de Navarra–Centro de Investigación Médica Aplicada,undefined
[26] Instituto de Investigación Sanitaria de Navarra,undefined
[27] Centro de Investigación Biomédica en Red de Cáncer,undefined
[28] University of Bologna,undefined
来源：
BMC Cancer | / 21卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Health-Related Quality of Life in a Randomized Phase III Study of Bevacizumab, Temozolomide, and Radiotherapy in Newly Diagnosed Glioblastoma
    Taphoorn, Martin J. B.
    Henriksson, Roger
    Bottomley, Andrew
    Cloughesy, Timothy
    Wick, Wolfgang
    Mason, Warren P.
    Saran, Frank
    Nishikawa, Ryo
    Hilton, Magalie
    Theodore-Oklota, Christina
    Ravelo, Arliene
    Chinot, Olivier L.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (19) : 2166 - +
  • [22] Etanercept improves the health-related quality of life of patients with psoriasis: Results of a phase III randomized clinical trial
    Feldman, SR
    Kimball, AB
    Krueger, GG
    Woolley, JM
    Lalla, D
    Jahreis, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (05) : 887 - 889
  • [23] Symptoms and health-related quality of life in patients with newly diagnosed multiple myeloma: a multicenter prospective cohort study
    Suzuki, Nana
    Okuyama, Toru
    Akechi, Tatsuo
    Kusumoto, Shigeru
    Ri, Masaki
    Inagaki, Atsushi
    Kayukawa, Satoshi
    Yano, Hiroki
    Yoshida, Takashi
    Shiraga, Kazuhide
    Hashimoto, Hiroya
    Aiki, Sayo
    Iida, Shinsuke
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (02) : 163 - 169
  • [24] EORTC phase III on PCV chemotherapy in newly diagnosed anaplastic oligodendrogliomas: Health-related quality of life results
    Taphoorn, M. J. B.
    van den Bent, M. J.
    Mauer, M.
    Coens, C.
    Delattre, J. -Y.
    Brandes, A. A.
    van der Rijt, C. C. D.
    Bernsen, H. J. J. A.
    Frenay, M.
    Tijssen, C. C.
    Lacombe, D.
    Allgeier, A.
    Bottomley, A.
    NEURO-ONCOLOGY, 2006, 8 (04) : 482 - 482
  • [25] Effect of initial treatment on health-related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect(R) MM Registry
    Abonour, Rafat
    Rifkin, Robert M.
    Gasparetto, Cristina
    Toomey, Kathleen
    Durie, Brian G. M.
    Hardin, James W.
    Terebelo, Howard R.
    Jagannath, Sundar
    Narang, Mohit
    Ailawadhi, Sikander
    Omel, James L.
    Lee, Hans C.
    Srinivasan, Shankar
    Kitali, Amani
    Agarwal, Amit
    Wagner, Lynne
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (01) : 93 - 100
  • [26] HEALTH-RELATED QUALITY OF LIFE ASSESSMENTS PREDICT RELAPSE OR DEATH IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (MM): RESULTS FROM THE CONNECT MM REGISTRY
    Wagner, I
    Dune, B. G.
    Jagannath, S.
    Narang, M.
    Terebelo, H. R.
    Gasparetto, C.
    Toomey, K.
    Hardin, J. W.
    Kitali, A.
    Yue, L.
    Agarwal, A.
    Srinivasan, S.
    Flick, E. D.
    Rifkin, R. M.
    Abonour, R.
    VALUE IN HEALTH, 2018, 21 : S6 - S6
  • [27] Factors that influence health-related quality of life in newly diagnosed patients with multiple myeloma aged ≥65 years treated with melphalan, prednisone and lenalidomide followed by lenalidomide maintenance: results of a randomized trial
    Dimopoulos, Meletios A.
    Palumbo, Antonio
    Hajek, Roman
    Kropff, Martin
    Petrucci, Maria Teresa
    Lewis, Philip
    Millar, Stefanie
    Zhang, Jingshan
    Mei, Jay
    Delforge, Michel
    LEUKEMIA & LYMPHOMA, 2014, 55 (07) : 1489 - 1497
  • [28] EFFECT OF TUMOR TREATING FIELDS (TTFIELDS) ON HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN NEWLY DIAGNOSED GLIOBLASTOMA. RESULTS OF THE EF-14 RANDOMIZED PHASE III TRIAL
    Taphoorn, Martin J. B.
    Dirven, Linda
    Taillibert, Sophie
    Honnorat, Jerome
    Chen, Thomas
    Sroubek, Jan
    Paek, Sun-Ha
    Escuder, Jordi Bruna
    Easaw, Jacob C.
    David, Carlos A.
    Kim, Chae-Yong
    Desai, Rajiv D.
    Kew, Yvonne
    Olivi, Alessandro
    Nicholas, Garth A.
    Lavy-Shahaf, Gitit
    Kirson, Eilon D.
    Ram, Zvi
    Stupp, Roger
    NEURO-ONCOLOGY, 2017, 19 : 206 - 206
  • [29] Phase III trial evaluating bortezomib in addition to melphalan/prednisone in newly diagnosed patients ineligible for transplantation
    Muneer, Sabeeha
    Cunningham, Sonia
    CLINICAL LYMPHOMA & MYELOMA, 2008, 8 (01): : 18 - 20
  • [30] Sustained Health-Related Quality of Life (HRQoL) Improvement in Newly Diagnosed Multiple Myeloma Patients Treated with Bortezomib/Melphalan/Prednisone Versus Melphalan/Prednisone: Results From the VISTA Trial.
    Dhawan, Ravinder
    Robinson, Don, Jr.
    Meunier, Juliette
    Regnault, Antoine
    Rosa, Kathleen
    Cakana, Andrew Z.
    van de Velde, Helgi
    Richardson, Paul G.
    San Miguel, Jesus F.
    BLOOD, 2009, 114 (22) : 747 - 747
12345